Colorectal cancer is a common disease, representing the third and second most common cause of cancer death in the United States in women and men, respectively. [Ahnen et al.: Mayo Clin Proc 2014;89:216-224; Siegel et al.: CA Cancer J Clin 2016;66:7]. It is estimated that 20% of patients have distant metastatic disease at time of diagnosis [Ahnen et al.: Mayo Clin Proc 2014;89:216-224; Siegel et al.: CA Cancer J Clin 2016;66:7]
Introduction
Colorectal cancer is a common disease process with approximately 130,000 new cases diagnosed annually in the United States [1, 2] . It represents the third most common cause of cancer death in women and the second in men in the United States as well [3] . However, the mortality of colorectal cancer has been declining by a rate of ~3% since 1990 [3] . Review of the current literature reveals that a majority of patients (86%) of those who are diagnosed with colorectal cancer under the age of 50 years are symptomatic when diagnosed [4] . At the time of presentation, it is estimated that 20% of patients have distant metastatic disease, and this finding is associated with a more advanced stage and generally, poorer outcomes [1, 2] . Metastatic colorectal cancer spreads via lymphatic and hematogenous distribution, as well as contiguous and transperitoneal routes [2] . The most common metastatic sites include regional lymph nodes, liver, lungs, and peritoneum; this is due to the venous drainage system of the intestinal tract, which utilizes the portal system leading to liver dissemination, followed by the lungs via the inferior rectal vein which drains into the inferior vena cava [2] . The symptoms at time of presentation are variable depending on the site of metastasis. Colorectal cancer has demonstrated some atypical presentations, for example, with local invasion or via malignant fistula into adjacent organs such as the bladder or small bowel. Additionally, it is estimated that colorectal cancer is the origin of 6% of adenocarcinomas of unknown primary sites [5] . Upon review of the literature, we found that metastatic colon cancer to the scrotum is a rare event. However, the following case report proved to be a unique example of this type of metastasis.
Case Presentation
A 54-year-old male with a 12-year history of urinary retention secondary to a traumatic, untreated saddle injury to the pelvis presented with scrotal pain, swelling, and malodorous discharge from the base of the scrotum. The patient stated that 6 months prior, he was treated for a presumed scrotal abscess with antibiotics. Physical exam was significant for a necrotic wound with an exposed caseous, fungating mass, which was draining urine and purulent exudate at the base of the edematous scrotum ( Fig. 1a) .
CT of the abdomen and pelvis demonstrated a heterogeneous multiloculated 9 × 9-cm scrotal mass as well as a 5.6-cm contrast-enhancing sigmoid, colonic mass (Fig. 1b) . Retrograde urethrogram revealed fistulous tracks, which interconnected between the rectosigmoid colon and the right scrotum. Further imaging and biopsies from the rectosigmoid mass and scrotal mass confirmed the diagnosis of adenocarcinoma of the sigmoid colon with regional scrotal metastasis, respectively, without evidence of lymphatic, liver, or bone involvement. The patient was initiated on capecitabine chemotherapy with consideration for future radiation and pelvic exoneration, which would require a penile resection and urostomy.
Discussion
This case report demonstrates a very unique occurrence. The most common primary tumors with metastasis to the scrotum are prostate, lung, melanoma, and kidney [2, 6, 7] . Upon literature review, we found that colon cancer metastasis to the scrotum is an extreme-ly rare event with an estimated occurrence of less than 20 reported cases [7, 8] . The majority of these cases presented with testicular swelling and pain, as was present in this case [9] . Current theories regarding scrotal metastasis hypothesize that this occurs via arterial tumor emboli or retrograde venous/lymphatic spread [3, 9, 10] . Given the previous history of a traumatic event, residual infection, and diagnostic studies demonstrating the presence of fistula tracts connecting the sigmoid colon and scrotum, this likely represents the etiology. The patient's primary malignancy of sigmoid adenocarcinoma was then able to metastasize to the scrotum via a contiguous route provided by the fistulas. Prognosis for this diagnosis is generally poor, with most patients' average survival of 6-12 months [7] . It is often frequently discovered that at this point there are metastases in other locations of the body. However, in this patient, the only evidence of malignancy was found at the site of metastasis (scrotum) and the primary source (sigmoid colon). Given the rarity of such an occurrence, it is uncertain how such a disease process will respond to therapy. This case provided a rare example of an uncommon contiguous metastasis of a primary malignancy. Fig. 1 . a Necrotic scrotal wound with an exposed fungating mass. b CT of the abdomen/pelvis demonstrating a multiloculated scrotal mass and a sigmoid mass.
